- Goldman Sachs downgraded Cognizant Technology Solutions Corp CTSH from Buy to Neutral. The price target for Cognizant Technology has been lowered from $68 to $61. Cognizant Technology shares fell 1.35 percent to $53.30 in pre-market trading.
- Analysts at Stifel Nicolaus downgraded AMC Networks Inc AMCX from Buy to Hold. AMC Networks shares fell 1.10 percent to $51.40 in pre-market trading.
- Gabelli & Co. downgraded Penske Automotive Group, Inc. PAG from Buy to Hold. Penske Automotive shares rose 0.53 percent to close at $49.40 on Wednesday.
- Analysts at Bank of America downgraded VF Corp VFC from Buy to Underperform. VF Corp shares dropped 3.08 percent to $56.25 in pre-market trading.
- CLSA downgraded Monsanto Company MON from Buy to Underperform. Monsanto shares dropped 0.08 percent to $106.67 in pre-market trading.
- Analysts at Credit Suisse downgraded Apigee Corp APIC from Outperform to Neutral. Apigee shares gained 0.03 percent to close at $17.45 on Wednesday.
- Analysts at BMO Capital downgraded Vitae Pharmaceuticals Inc VTAE from Outperform to Market Perform. Vitae Pharmaceuticals shares declined 0.24 percent to $20.80 in pre-market trading.
- Goldman Sachs downgraded Atara Biotherapeutics Inc ATRA from Neutral to Sell. The price target for Atara Biotherapeutics has been lowered from $23 to $16. Atara Biotherapeutics shares rose 1.81 percent to close at $21.33 on Wednesday.
- Barclays downgraded Arch Capital Group Ltd. ACGL from Overweight to Equal-weight. Arch Capital shares fell 0.53 percent to $80.22 in pre-market trading.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in